Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 52-69

  Paus, Elisabeth ^a   Nustad, K ^a   Bormer O P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibody specificity; Monoclonal antibody; Prostate specific antigen

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 2H11; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY E72; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E87; MONOCLONAL ANTIBODY E91; MONOCLONAL ANTIBODY F5; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY MM1; MONOCLONAL ANTIBODY MP2; MONOCLONAL ANTIBODY PR1; MONOCLONAL ANTIBODY PR12; MONOCLONAL ANTIBODY PS101; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSR217; MONOCLONAL ANTIBODY PSR222; MONOCLONAL ANTIBODY PSR233; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN BINDING; CLASSIFICATION; CONFERENCE PAPER; DISSOCIATION CONSTANT; EPITOPE MAPPING; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032726503     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056531     Document Type: Conference Paper

References (8)

1. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tulikanen K, Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-226.
2. Leinonen J, Zhang W-M, Stenman UH: Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155:1099-1103.
3. Mitrunen K, Pettersson K, Piironen T, Björk T, Lilja H, Lövgren T: Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem 1995;41:1115-1120.
4. Stamey TA, Prestigiacomo AF, Chen Z: Standardization of immunoassays for prostate specific antigen: A different view based on experimental observations. Cancer 1994;74:1662-1666.
5. Paus E, Børmer OP, Nustad K: Radioiodination of proteins with the IodoGen method; in Radioimmunoassay and Related Procedures in Medicine. Vienna, International Atomic Energy Agency, 1982, pp 161-171.
6. Graves HC: Issues on standardization of immunoassays for prostate-specific antigen: A review. Clin Invest Med 1993;16:415-424.
7. Strobel SA, Sokoloff RL, Wolfert RL, Rittenhouse HG: Multiple forms of prostate-specific antigen in serum measured differently in equimolar-and skewed-response assays. Clin Chem 1995;41:125-127.
8. Pettersson K, Piironen T, Seppälä M, Liukkonen L, Christensson A, Matikainen MT, Suonpää M, Lövgren T, Lilja H: Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem 1995;41:1480-1488.